Abstract
Abstract This report summarizes the evidence regarding adverse effects of diethylstilbestrol (DES) administration during pregnancy. From the association in 1969 of in utero DES exposure with subsequent increased risk of vaginal cancer in young women, the report includes the state of evidence regarding in utero DES exposure with other female genital tract abnormalities, with male genital tract abnormalities, with subsequent adverse reproductive experiences, and, among the exposed mothers, with increased risk of breast and other gynecologic cancers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
